Chronic persistent Epstein-Barr virus infection of natural killer cells and B cells associated with granular lymphocytes expansion

被引:29
作者
Kanegane, H [1 ]
Wado, T [1 ]
Nunogami, K [1 ]
Seki, H [1 ]
Taniguchi, N [1 ]
Tosato, G [1 ]
机构
[1] KANAZAWA UNIV, SCH MED, DEPT PAEDIAT, KANAZAWA, ISHIKAWA 920, JAPAN
关键词
Epstein-Barr virus; natural killer cells; granular lymphocyte proliferative disorder; polymerase chain reaction; in situ hybridization;
D O I
10.1046/j.1365-2141.1996.7532375.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
B lymphocytes and epithelial cells are the only cell types known to be infected with Epstein-Barr virus (EBV) in normal individuals. Rarely, EBV also infects other cells, including natural killer (NK) cells, almost always in the contest of fatal leukaemias or lymphoproliferative disorders, We report on a 6-year-old previously healthy girl who developed fevers and liver function abnormalities for 3 months. The peripheral blood revealed an abnormal expansion of large granular lymphocytes, comprising 24% of the white blood cells. Flow cytometric analysis of the peripheral blood mononuclear cells showed an abnormal increase of CD16-positive NK cells, 62% of which were EBV-infected by in situ EBER-1 hybridization. The circulating B cells were normal in number, but 18% were infected with EBV by in situ EBER-1 hybridization. Approximately 2 years after resolution of all symptoms and continued good health, 35% of the circulating mononuclear cells were EBV-infected, indicative of persistent expansion of EBV-infected cells. We conclude that abnormal expansions of EBV-infected NK and B cells can be associated with a chronic benign course.
引用
收藏
页码:116 / 122
页数:7
相关论文
共 30 条
[1]   MALIGNANT ANTIGRANULOCYTES LYMPHOPROLIFERATION AFTER EPSTEIN-BARR VIRUS-INFECTION - PARTIAL IMMUNOLOGICAL RECONSTITUTION WITH INTERLEUKIN-2 [J].
ARONSON, FR ;
DEMPSEY, RA ;
ALLEGRETTA, M ;
ANDRESCHWARTZ, J ;
POLDRE, PA ;
HILLYER, CD ;
PARKINSON, DR ;
RUDDERS, RA ;
SCHWARTZ, RS ;
MIER, JW .
AMERICAN JOURNAL OF HEMATOLOGY, 1987, 25 (04) :427-439
[2]  
CHAN WC, 1986, BLOOD, V68, P1142
[3]   EPSTEIN-BARR-VIRUS AND HODGKINS-DISEASE - TRANSCRIPTIONAL ANALYSIS OF VIRUS LATENCY IN THE MALIGNANT-CELLS [J].
DEACON, EM ;
PALLESEN, G ;
NIEDOBITEK, G ;
CROCKER, J ;
BROOKS, L ;
RICKINSON, AB ;
YOUNG, LS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :339-349
[4]   CD3-NEGATIVE LYMPHOPROLIFERATIVE DISEASE OF GRANULAR LYMPHOCYTES IN A GIRL WITH AN UNUSUAL PATTERN OF ANTI-EPSTEIN-BARR VIRUS-ANTIBODIES [J].
FUKUNAGA, Y ;
ASANO, T ;
TAKEHANA, J ;
AMBO, K ;
MATSUOKA, K ;
YAMAMOTO, M .
EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (12) :894-897
[5]  
HART DNJ, 1992, BLOOD, V79, P2116
[6]   EPSTEIN-BARR VIRUS SPECIFIC DIAGNOSTIC TESTS IN INFECTIOUS-MONONUCLEOSIS [J].
HENLE, W ;
HENLE, GE ;
HORWITZ, CA .
HUMAN PATHOLOGY, 1974, 5 (05) :551-565
[7]   DETECTION OF EPSTEIN-BARR-VIRUS TRANSCRIPTS IN CHEMICALLY OR IMMUNOLOGICALLY-ACTIVATED CELLS AND IN A NULL CELL-LINE (HLN-STL-C) BY IN-SITU HYBRIDIZATION WITH ALKALINE PHOSPHATASE-LINKED OLIGONUCLEOTIDE PROBES [J].
HIRONAKA, T ;
NAGASAKI, M ;
MORIKAWA, S ;
HIRAI, K .
JOURNAL OF VIROLOGICAL METHODS, 1993, 44 (2-3) :141-154
[8]   T-CELL LYMPHOMAS CONTAINING EPSTEIN-BARR VIRAL-DNA IN PATIENTS WITH CHRONIC EPSTEIN-BARR VIRUS-INFECTIONS [J].
JONES, JF ;
SHURIN, S ;
ABRAMOWSKY, C ;
TUBBS, RR ;
SCIOTTO, CG ;
WAHL, R ;
SANDS, J ;
GOTTMAN, D ;
KATZ, BZ ;
SKLAR, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (12) :733-741
[9]   INFECTION OF HUMAN ENDOTHELIAL-CELLS WITH EPSTEIN-BARR-VIRUS [J].
JONES, K ;
RIVERA, C ;
SGADARI, C ;
FRANKLIN, J ;
MAX, EE ;
BHATIA, K ;
TOSATO, G .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 182 (05) :1213-1221
[10]   Expression of L-selectin (CD62L) discriminates Th1- and Th2-like cytokine-producing memory CD4(+) T cells [J].
Kanegane, H ;
Kasahara, Y ;
Niida, Y ;
Yachie, A ;
Sugii, S ;
Takatsu, K ;
Taniguchi, N ;
Miyawaki, T .
IMMUNOLOGY, 1996, 87 (02) :186-190